期刊文献+

miR-301在结肠癌细胞增殖和凋亡中的作用 被引量:2

The role of miR-301 in colon cancer cell proliferation and apoptosis
下载PDF
导出
摘要 背景与目的:miR-301在多种恶性肿瘤中表达上调,然而其在结肠癌中的表达及功能尚不清楚。本研究旨在检测微小RNA miR-301在结肠癌组织中的表达,并在体内外研究miR-301反义寡核苷酸技术(ASO)对结肠癌细胞增殖和凋亡的影响。方法:运用荧光定量PCR定量分析120例结肠癌患者癌组织及对应癌旁组织中miR-301的表达;通过miR-301ASO降低结肠癌SW620细胞中miR-301的表达,采用MTT、克隆形成实验、流式细胞技术及体内实验观察miR-301ASO对SW620细胞产生的生物学效应。结果:在120例结肠癌患者中,63.33%(76/120)的结肠癌组织miR-301表达明显高于对应癌旁组织(P=0.00);与对照组miR-301的表达量(0.50±0.07)相比,miR-301ASO组可以显著降低miR-301的表达(0.09±0.01,P=0.00);MTT实验结果显示,转染miR-301 ASO组24、48、96 h SW620细胞的存活数量均明显低于对照组(P<0.05);克隆形成实验结果显示,miR-301ASO组克隆形成率(5.33%±0.74%)较对照组(33.33%±8.38%)显著降低(P=0.00);体内研究进一步证实miR-301ASO可以抑制肿瘤细胞的增殖,从而导致肿瘤生长较对照组慢(P=0.01),肿瘤的体积较对照组明显减小(P=0.01);流式细胞仪检测显示,转染miR-301ASO组SW620细胞凋亡指数(15.68±1.46)较随机染转染ASO组(3.36±0.88)明显增高(P=0.02);另外,降低miR-301的表达发现Bcl-2的mRNA和Bcl-2蛋白均明显下降(P=0.00,P=0.00)。结论:miR-301在结肠癌组织中表达上调,降低miR-301的表达可有效抑制结肠癌细胞生长、促进细胞凋亡。miR-301有可能成为结肠癌基因表达调控的新靶点。 Background and purpose: The miR-224 in a variety of malignant tumors is overexpression, however, its expression and function in colon cancer are not clear. The aim of this study was to investigate the expression of miR-301 in colon cancer tissues and demonstrate the regulative effects of miR-301 ASO on the proliferation and apoptosis of colon cancer cell in vitro and in vitro. Methods: The expression of miR-301 in 120 colon cancer tissues and their adjacent tissues was detected by real-time quantitative PCR method. After transfection with miR-301ASO, the biological effects of miR-301 in SW620 cells were measured by MTT assay, the colony formation experiment, flow cytometry and the in vivo experiment. Results: The expression level of miR-301 was found to be overexpressed in 63.33% (76/120) of the colon cancer cases (P〈0.05). miR-301 expression in SW620 cells (transfection with miR-301 ASO, 0.09±0.01) was significantly less than control group (0.50±0.07, P=0.00). MTT assay results showed that SW620 cells survived rate at 24, 48 and 96 h decreased greatly after transfection with miR- 301ASO (P=-0.00). Clone formation assay revealed that miR-301 ASO group colony formation rate (5.33%±0.74%) was significantly lower than the control group (33.33%±8.38%, P=-0.00). In vivo study further confirmed that miR- 301ASO could inhibit the proliferation of SW620 cells (P〈0.05), and miR-301ASO group grew substantially slow compared with the negative control group (P=0.00). Flow cytometry indicated that the apoptotic index in miR-301 ASO group (15.68±1.46) was significantly higher than the control group (3.36±0.88, P=0.02). In addition, the Bcl2 mRNAand protein were significantly decreased after reduce the expression of miR-301 (P=0.00, P=-0.00). Conclusion: MiR- 301 was overexpressed in human colon cancer. Reduce the expression of miR-301 can effectively inhibit the growth of colon cancer cells and promote apoptosis. MiR-301 may become a new target for the regulation of gene expression in colon cancer.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2013年第6期432-438,共7页 China Oncology
关键词 miR-301 结肠癌 反义单核苷酸 MiR-301 Colon cancer Antisense oligonucleotides
  • 相关文献

参考文献12

  • 1KALA R, PEEK G W, HARDY T M, et al. MicroRNAs:an emerging science in cancer epigenetics [ J ] . J ClinBioinforma. 2013, 3(1): 6.
  • 2GURTAN A M, SHARP P A. The Role of miRNAs inRegulating Gene Expression Networks [ J」.J MolBiol, 2013. pii: S0022-2836(13)00154-X. doi: 10.1016/j.jmb.2013.03.007. [ Epuh aheafl of print ].
  • 3SHI W, GERSTER K, ALAJEZ N M, et al. MicroHNA-301mediates proliferation and invasion in human breast cancer[J ] . Cancer Kes, 2011. 71(8): 2926-2937.
  • 4LEE E J, GUSEV Y, JIANG J. et al. Expression profilingidentifies mif-roRNA signature in pancreatic cancer [ J ] . IntJ Canoer, 2007, 120(5): 1046-1054.
  • 5JIANG J, GUSEV Y, A I) E H C A I, et al. Association ofMicroHNA expression in hepalooellular carcinomas withhepatitis infection, cirrhosis, and patient survival [ J J . ClinCancer Res, 2008. 14(2): 419-427.
  • 6BH.VrrACHAHVA A, TUROWSKI S G, SAN MARTIN I D,et al. Magnetic resonance anrl fluorescence-protein imagingof the anti-angiogenir and anti-tumor efficacy of selenium inan oilhotopic model of human colon rancer [ J ] . AntirancerRes, 2011.31(2):387-393.
  • 7CROCE C M. Causes and consequences of microRN Adysregulation in rancer [ J ] . Nat Rev Genet, 2009, 10(10):704-714.
  • 8STEFANI G, SLACK F J. Small non-ooding HNAs in animaldevelopment [ J ] . Nat Kev Mol Cell Biol, 2008, 9(3): 219-230.
  • 9MANIKANDAN J, AARTHI J J, KUMAR S D, et al. Oncomirs:the potential role of non-coding microHNAs in understandingcancer [J].Bioinformation, 2008. 2(8): 330-334.
  • 10NANA-SINKAM S P, CROCE C M. Clinical applicationsfor microRNAs in canoe r [ J ] . Clin Pharmacol Ther. 2013,93(1): 98-104.

同被引文献35

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部